Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.
Bazarbachi A, Labopin M, Ghavamzadeh A, Giebel S, Al-Zahrani H, Ladeb S, Leone G, Abdel-Rahman F, Liso V, Hamidieh AA, Rasheed W, Ibrahim A, Alabdulaaly A, Kyrcz-Krzemien S, Arnold R, Kharfan-Dabaja MA, Alimoghaddam K, Aljurf M, Mohty M. Bazarbachi A, et al. Bone Marrow Transplant. 2013 Aug;48(8):1065-9. doi: 10.1038/bmt.2013.1. Epub 2013 Jan 28. Bone Marrow Transplant. 2013. PMID: 23353802
Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
Claviez A, Canals C, Dierickx D, Stein J, Badell I, Pession A, Mackinnon S, Slavin S, Dalle JH, Chacón MJ, Sarhan M, Wynn RF, Suttorp M, Dini G, Sureda A, Schmitz N; Lymphoma and Pediatric Diseases Working Parties. Claviez A, et al. Blood. 2009 Sep 3;114(10):2060-7. doi: 10.1182/blood-2008-11-189399. Epub 2009 Jun 4. Blood. 2009. PMID: 19498021 Free article.
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
Kharfan-Dabaja MA, Otrock ZK, Bacigalupo A, Mahfouz RA, Geara F, Bazarbachi A. Kharfan-Dabaja MA, et al. Among authors: bazarbachi a. Bone Marrow Transplant. 2012 Sep;47(9):1254-5. doi: 10.1038/bmt.2011.257. Epub 2012 Jan 16. Bone Marrow Transplant. 2012. PMID: 22246089 No abstract available.
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.
Ayas M, Nassar A, Hamidieh AA, Kharfan-Dabaja M, Othman TB, Elhaddad A, Seraihy A, Hussain F, Alimoghaddam K, Ladeb S, Fahmy O, Bazarbachi A, Mohamed SY, Bakr M, Korthof E, Aljurf M, Ghavamzadeh A. Ayas M, et al. Among authors: bazarbachi a. Bone Marrow Transplant. 2013 Sep;48(9):1168-72. doi: 10.1038/bmt.2013.35. Epub 2013 Apr 1. Bone Marrow Transplant. 2013. PMID: 23542225
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.
Mohty M, Hübel K, Kröger N, Aljurf M, Apperley J, Basak GW, Bazarbachi A, Douglas K, Gabriel I, Garderet L, Geraldes C, Jaksic O, Kattan MW, Koristek Z, Lanza F, Lemoli RM, Mendeleeva L, Mikala G, Mikhailova N, Nagler A, Schouten HC, Selleslag D, Suciu S, Sureda A, Worel N, Wuchter P, Chabannon C, Duarte RF. Mohty M, et al. Among authors: bazarbachi a. Bone Marrow Transplant. 2014 Jul;49(7):865-72. doi: 10.1038/bmt.2014.39. Epub 2014 Mar 31. Bone Marrow Transplant. 2014. PMID: 24686988 Review.
Essential requirements for setting up a stem cell processing laboratory.
Leemhuis T, Padley D, Keever-Taylor C, Niederwieser D, Teshima T, Lanza F, Chabannon C, Szabolcs P, Bazarbachi A, Koh MB; Graft Processing Subcommittee of the Worldwide Network for Blood and Bone Marrow Transplantation (WBMT). Leemhuis T, et al. Among authors: bazarbachi a. Bone Marrow Transplant. 2014 Aug;49(8):1098-105. doi: 10.1038/bmt.2014.104. Epub 2014 Jun 16. Bone Marrow Transplant. 2014. PMID: 24933209
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT.
Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Hamladji RM, Blaise D, Socié G, Lioure B, Bermudez A, Lopez-Corral L, Or R, Arcese W, Fegueux N, Nagler A, Mohty M. Kharfan-Dabaja MA, et al. Among authors: bazarbachi a. Bone Marrow Transplant. 2014 Sep;49(9):1170-5. doi: 10.1038/bmt.2014.133. Epub 2014 Jun 30. Bone Marrow Transplant. 2014. PMID: 24978140
395 results